Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2022

Sep 1, 2022

65058_rns_2022-09-01_82cea9f6-0f56-4f9b-bb8b-9937c79af03f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entityHEALIUS LIMITED Name of entityHEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Jennifer Macdonald
Date of last notice 24 February 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest. N/A
Date of change 02 September 2022
No. of securities held prior tochange 6,024 NED Share RightsJennifer Macdonald6,024 Ordinary Shares*Jennifer Macdonald35,000 Ordinary SharesJennifer Macdonald* Shares are subject to a holding lock as “Restricted Securities”under the NED Share Plan.
Class Fully paid Ordinary Shares
Number acquired 6,024
Number disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation $30,000 cash equivalent using the volume weightedaverage price of Ordinary Shares over the five businessdays immediately following the Healius Limited AnnualGeneral Meeting on 21 October 2021, being $4.98.
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held afterchange 12,048 Ordinary Shares*Jennifer Macdonald35,000 Ordinary SharesJennifer Macdonald* Shares are subject to a holding lock as “Restricted Securities”under the NED Share Plan.
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back Vesting of remaining 50% of NED Share Rights issuedin respect of FY 2022 into Ordinary Shares (restricted)under the NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 02 September 2022

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011